Banque Pictet & Cie’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103M Buy
409,324
+36,840
+10% +$7.93M 0.64% 24
2026
Q1
$81M Sell
372,484
-16,440
-4% -$3.65M 0.57% 23
2025
Q4
$88.9M Buy
388,924
+54,953
+16% +$12.5M 0.52% 22
2025
Q3
$77.3M Buy
333,971
+157,480
+89% +$32.1M 0.45% 24
2025
Q2
$32.8M Sell
176,491
-1,853
-1% -$344K 0.23% 55
2025
Q1
$37.4M Buy
178,344
+103,887
+140% +$20.2M 0.3% 43
2024
Q4
$13.2M Sell
74,457
-29,162
-28% -$5.36M 0.09% 83
2024
Q3
$20.5M Buy
103,619
+3,985
+4% +$744K 0.16% 66
2024
Q2
$17.1M Buy
99,634
+13,297
+15% +$2.2M 0.15% 65
2024
Q1
$15.7M Sell
86,337
-6,070
-7% -$1.05M 0.15% 66
2023
Q4
$14.3M Sell
92,407
-103,766
-53% -$15.1M 0.12% 73
2023
Q3
$29.2M Buy
196,173
+20,691
+12% +$3.04M 0.35% 46
2023
Q2
$23.6M Buy
175,482
+11,814
+7% +$1.73M 0.21% 63
2023
Q1
$26.1M Sell
163,668
-9,950
-6% -$1.52M 0.25% 54
2022
Q4
$28.1M Buy
173,618
+32,706
+23% +$5.01M 0.29% 50
2022
Q3
$18.9M Buy
140,912
+87,164
+162% +$12.5M 0.21% 60
2022
Q2
$8.23K Buy
53,748
+51,029
+1,877% +$7.8M 0.08% 109
2022
Q1
$441K Buy
+2,719
New +$395K ﹤0.01% 537
2021
Q4
Sell
-3,239
Closed -$349K 617
2021
Q3
$349K Buy
+3,239
New +$370K ﹤0.01% 308
2020
Q4
Sell
-52,936
Closed -$4.64M 322
2020
Q3
$4.64M Sell
52,936
-175
-0.3% -$16.5K 0.07% 138
2020
Q2
$5.21M Buy
53,111
+8,524
+19% +$751K 0.09% 128
2020
Q1
$3.4M Buy
44,587
+5,181
+13% +$441K 0.07% 144
2019
Q4
$3.49M Sell
39,406
-190
-0.5% -$15.8K 0.06% 169
2019
Q3
$3M Buy
39,596
+24,935
+170% +$1.71M 0.06% 166
2019
Q2
$1.07M Buy
14,661
+9,314
+174% +$732K 0.02% 216
2019
Q1
$431K Sell
5,347
-76,193
-93% -$6.23M 0.01% 269
2018
Q4
$7.52M Buy
81,540
+875
+1% +$76.9K 0.15% 94
2018
Q3
$7.63M Buy
80,665
+165
+0.2% +$15.6K 0.14% 110
2018
Q2
$7.46M Buy
80,500
+1,669
+2% +$163K 0.15% 108
2018
Q1
$7.46M Sell
78,831
-6,895
-8% -$757K 0.16% 113
2017
Q4
$8.29M Sell
85,726
-26,349
-24% -$2.48M 0.17% 90
2017
Q3
$9.96M Buy
112,075
+100
+0.1% +$7.61K 0.23% 75
2017
Q2
$8.12M Buy
111,975
+1,362
+1% +$91.6K 0.19% 89
2017
Q1
$7.21M Buy
110,613
+36,866
+50% +$2.32M 0.18% 90
2016
Q4
$4.62M Sell
73,747
-21,270
-22% -$1.3M 0.12% 108
2016
Q3
$5.99M Sell
95,017
-6,835
-7% -$442K 0.15% 86
2016
Q2
$6.31M Sell
101,852
-4,428
-4% -$270K 0.17% 84
2016
Q1
$6.07M Buy
106,280
+78,084
+277% +$4.35M 0.16% 82
2015
Q4
$1.67M Sell
28,196
-4,320
-13% -$249K 0.05% 171
2015
Q3
$1.77M Buy
32,516
+22,666
+230% +$1.48M 0.05% 169
2015
Q2
$662K Buy
9,850
+4,200
+74% +$274K 0.05% 184
2015
Q1
$331K Sell
5,650
-1,250
-18% -$75.5K 0.01% 367
2014
Q4
$452K Sell
6,900
-6,400
-48% -$403K 0.01% 325
2014
Q3
$768K Sell
13,300
-3,750
-22% -$208K 0.02% 254
2014
Q2
$962K Hold
17,050
0.02% 234
2014
Q1
$876K Hold
17,050
0.02% 230
2013
Q4
$900K Buy
+17,050
New +$838K 0.03% 222

Other funds holding ABBV

Banque Pictet & Cie's ABBV Position: Q2 2026 in Review

Banque Pictet & Cie increased its AbbVie (ABBV) stake by 9.9% in Q2 2026, buying an estimated $7.93M and bringing the position to 409,324 shares worth $103M. The position accounts for 0.64% of the portfolio, ranked #24.

Banque Pictet & Cie first reported a position in ABBV in Q4 2013 and has held it in 47 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Banque Pictet & Cie held 409,324 shares of AbbVie worth $103M as of Q2 2026.
  • Banque Pictet & Cie bought 36,840 AbbVie shares in Q2 2026, an estimated $7.93M.
  • AbbVie made up 0.64% of Banque Pictet & Cie's portfolio in Q2 2026, its #24 holding.
  • Banque Pictet & Cie first reported a position in AbbVie in Q4 2013 and has held it in 47 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.